PARIS–(BUSINESS WIRE)–In alignment with its strategic plan for progress and readiness for going public, biolog-id, a worldwide chief within the traceability of delicate therapeutic merchandise, reinforces its government group by appointing Eric Dutang as Chief Monetary Officer and Deputy CEO. Inside biolog-id Govt Committee he can even oversee the Human Assets, Info Know-how & Authorized help capabilities. This appointment has come into impact on December 3rd, 2021.
All through his profession, Eric Dutang has acquired an in depth expertise and demonstrated his experience in numerous monetary sectors each for the European and North American markets. He started his profession by finishing up audit assignments for French and American main corporations, earlier than becoming a member of KPMG Transaction Providers as Monetary Due Diligence Advisor for 7 years. After that, he participated within the worldwide improvement of listed French corporations in Poland and China, earlier than providing his competencies to Alvest, an organization specialised in tools for the aviation trade. In 2015, he joined the biopharmaceutical firm Cellectis as Group CFO, the place he undertook to remodel numerous capabilities and performed strategic fundraisings in the US to help the group progress, together with Preliminary Public Providing.
“I’m very excited to welcome Eric Dutang to the biolog-id group. His deep-business background, particularly in publicly traded corporations, is a good addition to our group,” says Troy Hilsenroth, CEO at biolog-id. “His experience straddling each the French and the US markets will make the required connection between our historic website and our enlargement tasks.”
“It’s a actual honor to hitch biolog-id on this thrilling journey. On account of my earlier expertise in an analogous healthcare construction and the expertise I’ve earned with listed corporations, I’m assured that I could positively contribute the biolog-id improvement. I’m dedicated to creating the forthcoming challenges a hit.”, explains Eric Dutang.
Eric (48) is French native and resides in New-York USA. He’s licensed as a Public Accountant and holds an Govt MBA from HEC Paris (France) / Babson Massachusetts (USA).
Biolog-id develops and implements revolutionary options, that digitally rework routine processes into actionable information supporting higher operational and strategic selections for delicate therapeutic merchandise.
The knowledge generated by biolog-id options is out there to Healthcare Professionals at any time, enhancing their processes effectivity, work situations and in the end the protection of the therapeutics administered to sufferers.
Biolog-id’s patented platform is utilized in North America, Europe, Center East, India, and Asia Pacific. Biolog-id is owned by its founder, managers, and Xerys Make investments. Xerys Make investments is a French funding firm primarily positioned on trending sectors that embrace healthcare & Life Sciences, renewable vitality/GreenTech and new digital applied sciences.
Firm URL: www.biolog-id.com